who uses bpc 157 BPC-157 Peptide Therapy The Hidden Risks of BPC‑157:

Huang T, Zhang K, Sun L, et al

In a pilot trial of NAD+ intravenous infusion in healthy adults, subjects receiving 750 mg of NAD+ over 6 hours reported no negative symptoms, and there were no vital sign abnormalities or serious laboratory derangements compared to placebo

Shadid 2012

The cost of lower eyelid surgery varies from patient-to-patient depending on factors including the type of anesthesia used, the techniques used during your procedure, and the extent of correction necessary

And do they even work

While impeccable technique and storage can ensure you get the full 28 days of viability, pushing beyond that timeframe is a gamble against microbiologyand the house always wins